Jamjoom Pharma’s board proposes $28mln dividends

FAISAL NASSER

The suggested dividends amount to SAR 1.50 per share to be distributed to 70 million eligible shares

Staff Writer, Mubasher

April 4, 2024

PHOTO

The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recommended the distribution of SAR 105 million in cash dividends for 2023.

The suggested dividends amount to SAR 1.50 per share to be distributed to 70 million eligible shares, according to a bourse filing.

Jamjoom Pharma posted a net profit of SAR 292.40 million in 2023, up from SAR 171.31 million in 2022.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.